Axa’s quarterly results disclosure provided some relief to investors with no change in the French insurer’s previously disclosed Covid-19 estimate of €1.5bn ($1.75bn) and further indications of performance improvement within its Axa XL division.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: